4-5, May 2018
We are pleased to announce the 2nd Annual European Symposium on Lung Cancers™, which will focus on how clinicians can best incorporate new approaches, including personalized medicine, targeted agents, and immunotherapy. While these new approaches hold the promise of improved outcomes for patients with lung cancer, they also lead to increased demand on physicians to understand new paradigms in molecular testing, treatment selection, and management of adverse events with new categories of therapies.
This highly interactive and practical program will include internationally recognized experts in lung cancer describing recent key studies in the field, as well as extensive case-based discussions that go beyond the data in addressing challenges faced in the clinic. This meeting will also enable participants to engage directly with experts and with their peers to share their perspectives, personal experiences, and approaches to optimizing care for their patients with lung cancer.
New for 2018!
We have added several new features to this year’s meeting to enhance the educational and collaborative experience for attendees. A multidisciplinary tumor board will demonstrate cross-disciplinary assessment of patient cases and selection of the optimal therapeutic interventions. A session will also be dedicated to the pulmonologist’s view of lung cancer screening, diagnosis, and multimodality therapy. Finally, an afternoon Poster Walk will allow attendees to share and discuss their clinical research with other investigators in the field.
2018 Featured Topics
This educational activity is directed toward medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists, as well as other healthcare professionals involved in the treatment and management of patients with lung cancer.
At the conclusion of this symposium, you should be better prepared to:
Oncology Briefings™: Updates in Therapeutic Options and Approaches for Tenosynovial Giant Cell Tumors
Apr 28, 2018
April 28, 2018
New York, NY